Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
The consequences of loss of muscle function are far reaching and include decrease of motor control and overall fitness, development of functional limitations and impairment, and long term disability
10.1038/s41598-019-52837-8 Sci
Summary of evidence Randomized clinical trials such as CREDENCE [52](Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation) and DAPA-CKD [53, 54] (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) evaluated sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with T2DM and DKD, proving the reduction of renal outcomes, such as progression to advanced kidney disease, the need for dialysis and renal death
Our approach centers on individualized care and provider review, rather than focusing on a single number on the scale
Zhuang H, Liang Z, Ma G, Qureshi A, Ran X, Feng C, et al
